Diabetes clinical lead roles named in good practice drive
The diabetes clinical leads have been announced for a national programme aiming to drive down ‘unwarranted variation of care’.
Dr Partha Kar, the associate national clinical director of diabetes with NHS England and consultant in diabetes and endocrinology at Portsmouth Hospitals NHS Trust, will work alongside Professor Gerry Rayman, who is a consultant physician at the Diabetes and Endocrine Centre and the Diabetes Research Unit at Ipswich Hospitals NHS Trust.
Together they have been recruited to the Get It Right First Time (GIRFT) project which has been designed to improve clinical quality and efficiency within the NHS by reducing unwarranted variations.
It comes after the Government announced in November 2016 that GIRFT would receive an additional £60 million funding to expand and accelerate delivery of the programme, which has now been extended to include 30 clinical specialities.
It uses trust data and insight from frontline healthcare professionals to identify differences in the way services are delivered. In addition, GIRFT also encourages the sharing of best practice between trusts and proposes improvements within specialties to help improve outcomes of people being treated and bring about efficiencies that can be ploughed back into services.
The orthopaedic pilot has already helped deliver efficiencies and savings of up to £30 million, with another £20 million forecast for 2015/16. But importantly, good patient outcomes and safety have remained paramount throughout the programme.
Professor Tim Briggs, chair of GIRFT and national director of clinical quality and efficiency at NHS Improvement, said: “I am delighted that we have attracted another high calibre group of extremely experienced and enthusiastic clinical leads into the GIRFT programme.
“The fact that each work stream is led by an expert in the speciality is a vital part of the GIRFT methodology, because it means trust clinicians know they are dealing with people who really understand the challenges they face.”
Dr Kar and Professor Rayman will be responsible for managing a review of diabetes care, visiting every trust that undertakes that service in England. They will look for unwarranted variations in care and outcomes using a detailed report of the trust’s own data. A national report will be produced for each work stream, detailing recommendations to improve care and patient outcomes, as well as highlighting examples of good practice. The new clinical leads will start work on their programmes by the end of the year.